| 000 | 01605 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513094249.0 | ||
| 264 | 0 | _c19961112 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a1352-0504 | ||
| 024 | 7 |
_a10.1111/j.1365-2893.1996.tb00079.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHourvitz, A | |
| 245 | 0 | 0 |
_aReactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report. _h[electronic resource] |
| 260 |
_bJournal of viral hepatitis _cJan 1996 |
||
| 300 |
_a37-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xanalysis |
| 650 | 0 | 4 |
_aHepatitis B Core Antigens _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aSex |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 700 | 1 | _aMosseri, R | |
| 700 | 1 | _aSolomon, A | |
| 700 | 1 | _aYehezkelli, Y | |
| 700 | 1 | _aAtsmon, J | |
| 700 | 1 | _aDanon, Y L | |
| 700 | 1 | _aKoren, R | |
| 700 | 1 | _aShouval, D | |
| 773 | 0 |
_tJournal of viral hepatitis _gvol. 3 _gno. 1 _gp. 37-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2893.1996.tb00079.x _zAvailable from publisher's website |
| 999 |
_c8733303 _d8733303 |
||